Corporate banner bearing the text: We Have Choosen Dermatology
"Research & Development Introduction"
Site Information
As one of the world's leading pharmaceutical companies, focusing on the research, development and marketing of dermatological solutions, Galderma's ultimate mission is to enhance life by offering patients new drugs with a high level of safety and efficacy.



Photographic image depicting lab technicians at work. Galderma has one of the world's largest R&D portfolios dedicated to dermatology. We have filed close to 1700 pharmaceutical registrations throughout the world, in all our areas of expertise: treatment for skin, hair and nails. Channeling its R&D investments primarily into prescription products, our research focuses on the following areas:
  1. Acne
  2. Fungal Nail Infections
  3. Non Melanoma Skin Cancers
  4. Photodamage
  5. Psoriasis
  6. Rosacea
  7. Hyperpigmentation Disorders

To drive growth, Galderma commits 13.4% of its annual revenue to research and development activities.

During the past twenty years, Galderma's research efforts have allowed the company to issue 1500 publications, develop more than 150 inventions and file 1700 national patents.

At Galderma, dermatology is a commitment. For more information, please visit the Galderma International website's Research & Development section.
 ©2008 Galderma (UK) Ltd.Click here to go back to the top